hg_105870.1

Basic information about the TSS

---

TSS ID: hg_105870.1 Species: human Chr: chr10		Start: 80454275 End: 80454288 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC093016 Distance: 0 GeneID: 81619 HGNC/MGI_ID: HGNC:23303 UniProt_ID:

Gene_name: tetraspanin 14 Gene_symbol: TSPAN14 Gene_synonyms: DC-TM4F2 MGC11352 Gene_source: HGNC:23303

TATA-Box annotation

---

Distance to TSS:	17
Nearest PromoterID:	NM_001351268
Entrez ID:	81619
Nearest Unigene:	Hs.308615
Nearest Refseq:	NM_030927
Nearest Ensembl:	ENSG00000108219
Gene Name:	tetraspanin 14
Gene Alias:	DC-TM4F2|TM4SF14|tspan-14
Gene Description:	tetraspanin 14
Gene Type:	protein-coding
CpG%:	0.195
GC%:	0.825871
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TSPAN14 p2@TSPAN14 p4@TSPAN14 p6@TSPAN14 p7@TSPAN14 p8@TSPAN14 p9@TSPAN14
Sample		p1@TSPAN14	p2@TSPAN14	p4@TSPAN14	p6@TSPAN14	p7@TSPAN14	p8@TSPAN14	p9@TSPAN14
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.49	0.78	0.58	0.19	0.00	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.12	3.84	0.20	0.20	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.80	1.74	0.19	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.94	0.42	0.00	0.21	0.62	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.60	1.35	0.22	0.22	0.45	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.95	1.16	0.19	0.19	0.00	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.98	1.96	0.22	0.22	0.44	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.84	1.45	0.00	0.24	0.48	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.11	0.85	0.43	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	1.16	0.58	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.51	0.81	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.50	0.41	0.81	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.89	4.84	0.32	0.81	0.81	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.59	4.66	0.45	0.75	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.32	3.29	0.66	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.62	4.02	1.26	1.01	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.50	5.02	0.87	0.44	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.04	4.22	0.42	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.86	3.73	0.00	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.91	3.46	0.60	0.75	0.60	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.26	4.14	1.07	0.53	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.27	5.35	0.69	0.69	0.35	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.42	4.91	1.03	1.29	0.39	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.57	3.15	0.97	0.73	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.67	3.10	1.55	1.03	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.37	3.48	0.63	0.32	0.00	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.68	0.55	0.55	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.87	5.19	1.18	0.47	0.47	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.74	5.01	0.16	0.48	0.32	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.46	3.98	0.72	0.90	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	4.19	0.42	0.00	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.17	3.91	0.39	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.15	3.80	0.42	0.63	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.48	3.96	0.82	0.66	0.49	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.95	3.74	0.19	0.37	0.37	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.55	2.49	0.57	0.19	0.38	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.74	2.66	0.82	0.61	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.95	2.22	0.81	0.20	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.80	2.16	0.81	0.00	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.40	2.64	0.00	1.44	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.35	3.53	0.24	0.71	0.24	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.47	1.90	0.29	0.44	0.29	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.98	3.59	0.21	0.63	0.00	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	15.38	5.24	0.00	0.17	0.52	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.25	2.61	0.80	0.20	0.80	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.31	3.02	1.16	0.23	0.70	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.59	5.04	0.48	0.48	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.39	3.58	0.60	0.30	0.60	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.70	4.79	0.72	0.00	0.48	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.24	6.07	0.61	0.81	0.40	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.73	5.12	1.23	0.61	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.80	3.34	0.44	0.00	0.22	0.00	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.49	1.77	0.71	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.16	5.63	0.66	0.66	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	3.36	0.00	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	2.30	0.00	0.46	1.38	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.72	4.21	0.65	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.26	4.18	1.93	0.00	0.64	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.12	4.71	0.63	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.01	6.35	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.89	5.61	2.24	0.56	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	26.27	6.37	0.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.14	0.68	0.00	0.34	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.67	3.25	0.32	0.65	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	27.33	4.61	1.42	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.64	4.88	0.00	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	2.98	0.50	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.68	4.22	0.94	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.21	2.32	0.99	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.49	4.64	0.93	0.31	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	22.01	5.50	0.00	0.61	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	16.31	3.17	0.63	0.00	0.32	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	46.04	3.53	0.00	0.48	0.48	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	24.43	1.78	0.51	0.64	0.25	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	11.21	4.48	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	34.83	2.34	0.33	0.33	0.00	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	2.55	0.00	0.00	0.00	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	4.40	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	46.07	3.16	0.00	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	79.24	6.95	0.70	1.74	0.00	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	56.32	6.65	0.59	0.78	0.39	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	23.68	1.80	0.26	0.51	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	63.28	5.58	0.84	0.56	0.28	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	67.60	1.76	0.00	0.00	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	116.71	8.04	0.48	0.88	1.05	0.16	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	59.71	1.61	0.65	0.65	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	65.05	2.67	0.00	1.60	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	91.26	1.67	0.00	0.00	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	111.46	7.90	0.83	1.25	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	77.36	2.26	0.50	0.75	0.50	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	84.76	3.60	0.98	0.65	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	73.68	2.74	0.00	0.30	0.30	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	64.31	7.96	0.88	0.44	0.22	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	65.26	8.96	0.72	0.72	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	28.75	3.59	0.00	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	71.24	6.66	0.90	1.44	0.18	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	70.29	5.02	1.67	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	67.59	8.63	0.62	0.41	0.82	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	31.92	6.29	0.92	0.92	0.23	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	29.14	5.88	0.24	0.98	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.97	3.15	0.00	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	61.21	3.47	0.43	0.87	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	57.79	4.28	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	54.10	3.59	0.60	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	49.32	2.53	1.26	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	61.39	4.62	0.00	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.96	2.92	0.65	0.65	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	58.25	7.28	0.00	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	46.92	1.19	0.00	0.00	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	51.98	4.52	0.75	0.75	0.00	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	44.27	5.81	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	3.76	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	50.41	5.44	0.66	1.65	0.82	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	49.13	0.00	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	40.86	4.67	0.60	0.45	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.69	3.21	0.54	1.07	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	38.54	3.78	0.38	0.94	0.38	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	42.77	2.14	0.00	0.27	0.53	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	0.98	0.98	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	33.17	1.99	0.83	0.66	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	3.60	0.00	0.00	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.65	4.46	0.51	0.51	0.51	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	50.00	2.43	0.49	0.97	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.19	2.66	0.76	0.38	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	2.42	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	50.16	3.99	0.57	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.53	5.13	0.64	0.43	0.43	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	34.84	4.90	0.52	1.03	0.77	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	44.57	1.88	0.94	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	56.59	4.50	0.32	0.32	0.96	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	43.52	6.42	0.00	0.71	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	54.40	2.34	0.00	0.58	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	51.48	3.61	0.30	0.60	2.11	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	53.46	5.94	0.00	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	47.80	5.59	2.03	0.51	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	50.68	4.84	0.51	2.04	0.76	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	33.67	5.72	1.27	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	52.65	4.32	0.86	1.73	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	47.63	4.02	1.27	1.48	0.64	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	41.18	3.77	0.29	0.87	1.16	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	4.72	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.70	5.59	0.34	0.68	0.34	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	44.81	4.72	1.07	0.43	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	48.73	2.41	1.20	0.00	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	6.56	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	35.40	3.22	0.46	0.92	1.15	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	51.01	7.65	2.55	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.37	2.54	0.76	1.02	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	43.56	4.34	0.62	0.62	0.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.74	4.90	0.00	2.45	0.61	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	4.30	0.48	0.48	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.24	4.66	0.22	0.89	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	3.05	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	4.43	0.55	1.66	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	45.28	2.65	0.26	0.79	0.79	0.00	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	42.52	3.63	1.45	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	40.28	7.12	0.86	1.35	0.25	0.25	0.49
Astrocyte - cerebellum, donor2	11580-120F5	43.30	8.04	1.20	1.03	0.34	0.00	1.03
Astrocyte - cerebellum, donor3	11661-122F5	29.15	10.49	1.47	1.05	0.63	0.00	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	41.48	8.71	1.05	1.39	0.35	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	48.37	9.06	2.26	1.46	0.32	0.00	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	36.99	11.49	1.19	0.89	0.00	0.15	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.72	4.59	0.92	0.92	0.00	0.11	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	28.19	6.14	1.13	0.75	0.00	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.21	3.07	0.68	0.68	0.23	0.46	0.68
Basophils, donor1	12241-129G9	87.35	3.14	0.00	0.26	0.00	0.52	0.00
Basophils, donor2	12242-129H1	78.65	2.53	0.00	0.36	0.00	0.72	0.36
Basophils, donor3	12243-129H2	85.99	2.79	0.29	0.29	0.15	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	53.90	4.74	0.22	0.43	0.22	3.88	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	61.26	3.66	0.00	0.46	0.00	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	55.23	4.39	0.00	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	48.24	5.61	0.83	0.62	0.00	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	38.92	3.45	0.23	0.00	0.00	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	35.99	4.32	0.00	0.36	0.00	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	26.49	4.43	0.93	1.44	0.00	0.41	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	58.46	5.59	0.93	1.40	0.23	2.79	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	19.83	3.52	0.64	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	80.59	5.07	0.00	0.56	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	93.36	3.90	0.56	0.56	0.00	0.74	0.56
CD14+ Monocytes, donor3	11381-118B4	82.11	3.73	0.88	0.66	0.22	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	173.22	6.51	0.00	0.85	1.13	3.40	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	136.47	5.69	0.38	1.14	1.52	2.65	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	154.84	4.60	0.33	1.31	0.33	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	90.78	2.46	0.43	0.29	0.00	0.29	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	78.15	2.41	0.00	0.60	0.00	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	94.52	3.32	0.24	0.24	0.24	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	57.08	2.01	0.17	0.33	0.00	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	43.06	1.38	0.55	0.00	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	47.60	0.74	0.25	0.50	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	53.06	1.96	0.20	0.20	0.20	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	50.21	1.78	0.36	0.36	0.00	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.94	0.44	0.00	0.44	0.00	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	81.71	2.81	0.23	0.47	0.00	0.70	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	79.73	0.53	0.53	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	88.75	4.44	0.00	1.11	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	64.56	1.78	0.45	0.15	0.00	0.15	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	43.30	2.00	0.20	0.20	0.20	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	41.22	1.25	0.00	0.00	0.00	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	81.45	2.06	0.23	0.23	0.46	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	48.86	0.90	0.00	0.00	0.23	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	67.21	0.87	0.00	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	106.79	1.61	0.27	0.54	0.00	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	93.86	3.49	0.17	0.17	0.35	0.70	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	124.56	2.10	0.42	0.42	0.84	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	117.02	2.39	0.18	0.00	0.00	1.29	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	64.46	1.76	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	88.62	2.19	0.00	0.00	0.00	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	44.99	0.87	0.17	0.00	0.17	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.43	1.49	1.12	0.37	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	60.14	0.86	0.00	0.22	0.00	1.08	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	104.01	0.82	0.82	0.41	0.00	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.33	0.46	0.46	0.00	0.00	0.46	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	72.61	1.16	0.23	0.00	0.70	0.70	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	140.37	2.83	0.00	0.22	0.00	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	151.76	3.00	0.46	0.92	0.23	1.62	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	134.52	3.68	0.65	0.00	0.22	1.95	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	117.73	3.58	0.47	0.47	0.16	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	89.42	4.19	0.52	0.52	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	111.26	2.45	0.22	0.67	0.00	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	180.41	3.06	0.51	0.77	0.00	3.32	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	180.70	4.61	0.88	0.44	0.00	1.76	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	210.12	4.21	0.00	0.42	0.00	2.53	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	2.03	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	24.41	2.03	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	1.04	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	29.85	3.73	0.53	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	2.14	0.54	0.54	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.06	1.40	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	3.92	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	1.32	1.32	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	38.63	1.64	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	42.07	2.90	0.00	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	38.87	3.03	0.00	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	117.58	12.12	0.40	3.64	0.00	6.46	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	93.48	10.79	0.80	1.20	0.00	5.99	0.80
CD34+ Progenitors, donor1	11545-120B6	15.06	1.00	1.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	42.14	3.37	0.00	0.00	0.00	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.20	1.88	0.75	0.00	0.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.77	3.16	0.45	0.90	0.23	0.45	0.68
CD4+ T Cells, donor1	11225-116C1	132.83	14.64	1.07	0.71	0.00	3.21	0.00
CD4+ T Cells, donor2	11306-117C1	127.37	6.74	1.22	0.00	0.00	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	146.40	11.59	1.22	1.22	0.00	2.44	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	85.50	1.53	0.51	0.51	0.00	31.65	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.88	3.59	0.22	1.35	0.00	26.95	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	84.80	3.16	0.86	0.86	0.00	29.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	130.38	8.53	0.95	0.00	0.00	8.53	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	167.15	9.13	0.00	1.40	0.00	3.51	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	151.63	16.48	3.30	0.00	0.00	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	85.12	6.21	0.72	0.87	0.00	13.87	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.24	6.10	0.51	0.51	0.00	18.98	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	76.57	6.61	0.48	1.13	0.00	17.41	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	123.28	6.72	0.45	1.79	0.00	4.03	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	129.97	7.34	0.35	1.40	0.00	5.94	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	127.59	6.16	0.44	0.44	0.00	5.28	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	110.05	2.11	0.42	0.42	0.00	11.38	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	85.81	6.65	0.83	0.42	0.00	8.52	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	86.54	4.34	0.67	1.00	0.00	4.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	207.49	11.15	2.72	1.63	0.00	11.69	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	229.92	13.40	0.00	1.61	0.00	9.11	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	191.88	8.97	0.00	0.00	0.00	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	123.87	4.08	0.74	1.11	0.00	16.87	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	119.79	4.98	0.43	1.30	0.00	9.96	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	152.78	7.78	0.21	1.26	0.00	19.96	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	152.69	9.10	0.51	0.00	0.00	8.09	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	131.28	9.96	0.43	0.87	0.00	6.07	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	158.64	5.67	1.31	0.00	0.00	9.15	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	145.99	10.89	0.99	1.98	0.00	5.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	139.40	6.46	1.85	0.92	0.00	4.62	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	118.64	11.17	1.40	4.19	0.00	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	184.99	10.52	0.55	1.66	0.00	7.48	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	175.21	10.80	0.49	0.74	0.00	7.85	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	141.68	10.78	0.00	0.00	0.00	6.16	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	153.63	10.39	0.00	1.43	0.00	6.80	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	132.96	5.54	1.38	0.00	0.00	8.31	0.00
CD8+ T Cells, donor1	11226-116C2	74.32	4.91	0.65	0.33	0.00	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	90.85	3.75	0.38	0.75	0.38	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	118.67	8.58	1.01	1.26	0.00	2.78	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.75	0.69	0.23	0.00	0.00	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.79	0.48	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.19	0.82	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.00	0.90	0.00	0.30	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.32	0.72	0.00	0.24	0.00	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.32	1.14	0.23	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.87	1.30	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.05	1.05	0.00	0.26	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.44	0.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.45	1.51	0.00	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.52	1.45	0.00	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.00	0.53	0.53	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.51	0.44	0.00	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.75	0.46	0.00	0.00	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	1.49	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.88	1.44	0.00	0.00	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.16	0.86	0.00	0.29	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.30	1.65	0.00	0.00	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	1.27	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	1.23	0.00	0.31	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	2.24	0.64	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.97	2.29	0.00	0.76	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.52	0.79	0.79	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	1.51	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	0.00	0.00	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.19	2.10	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	1.00	0.00	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	23.76	3.66	3.66	0.00	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	67.69	8.89	1.48	1.98	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.26	3.79	0.95	0.32	0.11	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	7.63	0.35	2.08	0.00	0.35	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	3.55	0.00	0.00	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.37	1.71	0.23	0.23	0.23	0.00	0.80
Chondrocyte - re diff, donor2	11339-117F7	6.27	0.90	1.79	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	4.45	0.40	0.00	0.40	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	38.10	8.49	2.18	0.69	0.69	0.11	1.95
Ciliary Epithelial Cells, donor2	11323-117D9	45.10	8.55	1.50	1.50	0.43	0.00	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	45.58	10.44	2.04	1.77	0.71	0.09	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	42.37	7.34	1.19	0.73	3.30	0.28	2.29
Corneal Epithelial Cells, donor1	11526-119I5	83.44	8.12	1.32	0.66	0.22	4.17	0.22
Corneal Epithelial Cells, donor2	11606-120I4	64.84	5.69	0.00	0.00	0.00	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	57.26	9.20	1.02	0.51	0.00	1.02	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.90	2.48	0.17	0.17	0.50	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	25.23	1.58	0.00	0.00	0.32	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	35.42	3.13	0.43	0.22	0.11	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	33.14	3.76	0.34	0.34	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.73	2.61	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	25.65	2.42	0.00	0.00	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	77.88	6.84	1.00	0.17	0.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	69.24	5.28	0.00	1.17	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	97.28	4.52	0.00	0.85	0.28	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	77.06	3.93	0.00	0.00	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	102.10	5.82	0.87	0.29	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	102.58	5.65	0.94	1.18	0.47	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	92.56	6.49	0.53	1.05	0.35	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	146.29	8.20	1.11	1.11	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	130.23	4.56	0.91	0.91	0.61	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	146.87	5.07	0.56	1.13	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	120.04	10.10	0.30	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	80.18	5.21	1.04	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	88.76	6.24	0.99	1.13	0.14	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	130.04	7.20	0.80	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	112.16	6.81	1.05	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	116.17	12.67	1.49	1.24	0.62	0.00	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	42.58	3.48	0.00	1.30	0.00	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	57.40	5.74	1.10	0.73	0.00	0.00	0.37
Endothelial Cells - Vein, donor1	11267-116G7	77.35	5.69	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	76.14	4.19	2.10	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	91.85	9.42	0.79	1.88	0.31	0.00	0.31
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	112.22	3.30	0.00	0.00	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	114.14	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	42.02	5.62	0.98	0.49	0.24	3.18	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	81.13	6.24	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	7.39	2.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.28	0.77	0.00	0.33	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.01	0.54	0.11	0.22	0.43	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.89	3.40	0.85	0.49	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.96	4.64	0.68	0.41	0.41	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.87	2.32	0.84	1.05	0.21	0.00	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	41.63	4.48	1.58	1.32	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.29	5.32	0.33	0.66	0.00	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	16.33	2.27	1.36	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	37.90	1.52	0.00	0.00	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	16.40	3.63	1.10	0.16	0.32	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	33.04	3.03	2.12	0.91	0.00	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	38.83	5.08	0.51	0.38	0.13	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	46.39	3.79	0.30	0.15	0.45	0.00	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	56.28	6.97	0.67	0.67	0.40	0.00	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.95	3.45	0.43	0.86	0.00	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	101.07	21.97	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	57.66	7.38	0.69	0.69	0.00	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	82.60	10.18	0.85	1.87	0.51	0.68	0.34
Fibroblast - Dermal, donor1	11269-116G9	43.43	5.87	0.70	0.94	0.47	0.23	1.17
Fibroblast - Dermal, donor2	11346-117G5	38.68	4.25	0.47	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.72	4.59	0.60	0.97	0.24	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	19.33	5.20	0.90	0.23	0.00	0.34	0.45
Fibroblast - Dermal, donor5	11454-119A5	26.17	5.76	1.22	1.05	0.00	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	36.87	5.85	0.81	1.14	0.00	0.00	0.65
Fibroblast - Gingival, donor1	11237-116D4	32.48	5.41	1.46	0.83	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.60	2.88	0.79	0.00	0.26	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	74.06	8.83	0.53	1.45	0.26	0.26	0.66
Fibroblast - Gingival, donor3	11394-118C8	26.78	5.51	1.06	0.77	0.19	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	0.00	0.00	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	3.17	0.88	1.06	0.00	0.00	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	7.17	2.49	0.47	0.47	0.00	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.20	2.70	0.27	0.54	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.70	3.18	1.06	0.71	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	8.04	2.19	0.29	0.15	0.00	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6.54	1.50	0.14	0.55	0.00	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	6.58	1.43	0.22	0.44	0.00	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	9.98	2.35	1.47	0.44	0.00	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	21.75	5.44	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	28.35	7.46	0.00	1.49	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	25.11	6.12	1.06	0.21	0.21	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	72.47	5.83	0.83	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	41.96	5.59	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	20.43	4.48	0.56	0.28	0.28	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	48.72	6.90	0.81	0.81	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	63.91	3.99	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	47.33	7.95	0.97	1.16	0.00	0.78	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	27.00	7.28	0.76	1.37	0.00	0.00	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.27	7.04	0.61	1.53	0.00	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.12	3.05	0.76	0.38	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.64	3.24	0.00	1.08	0.27	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.19	2.55	0.81	0.81	0.00	0.23	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	57.26	5.08	0.77	0.99	0.44	0.11	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	206.85	15.04	1.02	1.22	0.20	1.22	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	69.49	6.01	0.00	3.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.63	3.95	0.40	1.19	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	23.42	4.96	0.40	0.00	0.20	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	1.78	0.00	0.36	0.18	0.00	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.39	2.56	0.39	0.00	0.00	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.06	3.91	1.81	0.60	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.07	1.84	0.11	0.54	0.00	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.64	4.81	0.76	0.51	0.00	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	12.14	1.48	0.33	0.16	0.00	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.64	7.82	1.40	1.00	0.20	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	12.16	1.71	0.20	0.50	0.30	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	13.30	4.84	0.30	0.30	0.00	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.69	3.40	0.66	0.58	0.17	0.00	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.94	2.22	1.03	0.51	0.51	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	3.28	0.99	0.00	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.14	1.81	0.43	0.21	0.00	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	22.10	2.19	1.01	0.51	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.88	2.51	0.00	0.31	0.31	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	48.81	1.74	1.74	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	102.11	7.45	0.52	0.87	0.17	3.12	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	81.20	8.07	0.26	1.04	0.26	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	68.73	5.62	0.26	1.02	0.51	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	5.36	0.77	0.00	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	5.74	0.64	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	26.53	8.27	0.57	2.28	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.92	8.82	2.48	2.48	1.38	0.00	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	38.36	6.62	3.65	1.37	0.23	0.00	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	26.55	9.11	3.37	1.78	0.40	0.00	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.18	10.31	3.17	1.59	0.53	0.00	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.70	8.48	3.26	1.63	0.65	0.00	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	21.23	3.54	0.44	1.33	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.77	7.07	1.27	0.28	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.93	5.17	1.11	0.74	0.12	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.56	5.37	1.61	0.81	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.78	11.03	0.99	0.62	0.12	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.65	7.61	1.52	0.83	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.82	4.68	1.22	0.61	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.04	7.99	1.83	0.91	0.46	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.77	6.10	1.37	1.00	0.00	0.00	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.97	5.25	0.66	0.66	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	64.12	8.86	0.89	1.48	0.59	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.30	9.22	1.11	0.48	0.48	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.77	8.27	0.67	0.45	0.45	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	89.53	9.68	1.01	1.01	0.20	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	59.21	7.63	2.04	1.19	1.19	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	66.59	11.08	1.51	1.24	0.44	0.27	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	146.30	16.34	1.98	2.91	0.52	0.94	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	138.67	10.42	2.73	1.88	0.00	1.20	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	72.59	9.18	1.88	0.66	0.33	0.11	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	68.72	8.74	1.08	1.50	0.50	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	70.03	7.55	1.02	0.82	0.61	0.20	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	85.41	7.22	1.44	1.65	0.21	0.41	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	63.99	10.84	1.50	1.61	0.69	0.12	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	69.37	8.67	1.67	1.83	0.83	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	89.72	7.49	1.32	1.54	0.44	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	71.70	10.45	1.23	1.72	0.98	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	58.84	9.08	1.13	1.62	0.81	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	68.95	5.13	0.96	2.57	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	86.61	12.89	1.23	0.95	0.76	0.38	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	78.77	8.07	0.95	0.95	0.32	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	94.57	6.39	0.30	0.91	1.52	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	82.69	10.45	1.36	0.52	0.84	0.63	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	67.62	9.22	0.44	1.10	1.32	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	88.65	7.01	1.68	0.84	1.12	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	81.75	10.37	1.76	0.93	0.56	0.19	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	71.40	6.42	1.07	1.60	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	126.99	11.32	1.68	1.07	1.07	1.07	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	89.12	9.07	0.65	0.91	1.17	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	71.56	6.78	0.54	1.08	1.36	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	75.22	7.74	1.47	1.66	0.74	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	63.16	8.77	1.54	1.10	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	74.38	5.95	0.99	0.99	1.98	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	63.05	5.67	1.32	1.58	0.26	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	59.11	6.86	1.21	0.61	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	133.18	23.64	1.27	1.52	0.51	0.25	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	23.29	6.57	1.79	0.60	0.00	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.02	2.93	1.08	0.62	0.15	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.55	8.18	2.05	0.61	0.20	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	36.30	7.20	0.94	0.63	0.00	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.43	5.37	1.41	1.70	0.28	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.14	6.92	1.84	0.92	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	4.95	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	41.39	6.96	0.39	1.16	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	9.63	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	6.96	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	43.61	4.88	1.30	0.98	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.30	3.71	1.65	1.65	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	10.00	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.14	6.15	0.84	1.68	0.28	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	55.89	8.50	0.33	0.98	0.98	0.00	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.97	10.07	0.00	1.68	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	53.75	7.32	1.91	1.59	0.64	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	38.72	4.42	1.70	0.34	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	45.94	6.26	12.53	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.82	10.31	0.00	1.72	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	36.11	7.70	1.48	1.18	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	3.39	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.22	5.38	2.07	3.31	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	48.33	7.13	1.38	0.69	0.23	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.13	5.00	1.15	0.77	0.38	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.95	3.59	1.63	1.30	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.77	2.68	1.34	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.16	4.62	2.70	0.77	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	56.49	6.85	1.37	0.68	1.71	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	2.48	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	52.85	6.13	0.00	1.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	46.47	4.83	0.60	0.60	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	45.78	5.09	1.02	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	44.67	4.79	0.80	1.20	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.94	7.40	0.49	0.49	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	48.40	10.62	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	54.84	10.50	0.58	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.89	9.22	0.88	0.88	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	1.70	0.85	1.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	5.37	1.79	0.60	1.19	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.85	2.43	0.49	0.49	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	2.28	1.14	0.00	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	4.57	0.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	4.50	0.00	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	2.54	0.63	0.00	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	1.67	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.46	1.62	0.00	0.23	0.12	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.18	1.01	0.00	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	14.79	1.59	0.68	0.46	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	16.18	0.77	0.11	0.55	0.11	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.34	1.07	0.86	0.21	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.87	1.08	0.43	0.00	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.46	1.12	0.12	0.50	0.00	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.81	0.86	0.00	0.51	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.53	0.96	0.32	0.32	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	120.88	7.28	0.56	1.68	0.56	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	92.19	7.79	0.00	0.87	0.43	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	124.26	7.93	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.81	6.70	2.12	0.71	0.71	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	22.52	3.63	0.73	0.73	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.67	4.37	0.00	0.17	0.35	0.00	0.35
Hepatocyte, donor1	11523-119I2	10.90	2.42	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	32.32	0.00	0.00	1.08	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	23.93	1.84	1.23	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	9.14	0.65	0.00	1.31	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	96.65	6.82	0.35	0.35	0.17	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	70.11	9.74	1.10	1.51	0.00	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	48.45	5.54	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	7.51	0.00	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87	23.74	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	15.38	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	66.60	11.37	1.62	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	6.67	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	7.26	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	78.08	6.62	1.32	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	47.67	8.87	2.22	5.54	1.11	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.79	7.56	0.63	2.52	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	6.19	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	52.98	16.15	0.00	0.65	0.00	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	67.62	12.88	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	11.41	0.00	2.44	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	53.74	11.33	2.10	1.68	0.84	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	45.01	8.04	0.80	2.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	58.17	4.62	0.00	0.92	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.12	7.08	0.94	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	31.74	6.35	0.91	1.81	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	9.69	0.00	1.08	0.00	0.00	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	68.61	6.35	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.28	14.03	2.55	1.28	0.64	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	41.92	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	43.56	10.00	1.43	2.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	89.59	9.95	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	52.47	9.26	1.23	1.54	0.00	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	12.29	1.76	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	56.58	9.43	3.14	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.72	13.21	2.78	2.09	0.70	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	79.67	15.49	11.07	4.43	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	84.29	19.45	0.00	6.48	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	54.93	16.57	0.00	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	87.74	9.00	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	6.97	0.00	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	70.41	7.47	0.00	2.13	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	58.19	8.31	1.39	0.00	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	82.64	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	72.71	15.65	2.76	4.60	0.92	0.92	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	9.08	9.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	6.21	6.21	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	4.23	1.06	1.06	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	90.90	9.47	0.73	1.63	0.65	2.61	0.24
Keratinocyte - epidermal, donor2	11349-117G8	30.45	3.51	0.59	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	82.35	10.79	0.95	1.33	0.38	1.80	0.38
Keratinocyte - oral, donor1	11251-116E9	68.91	10.56	1.14	0.57	0.11	1.14	0.45
Keratocytes, donor1	11527-119I6	37.82	6.53	0.00	1.03	0.00	0.34	0.34
Keratocytes, donor2	11607-120I5	22.26	4.69	2.34	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	28.85	5.53	0.79	0.79	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	106.80	11.87	0.00	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	71.62	11.19	1.50	1.61	0.81	0.12	0.81
Lens Epithelial Cells, donor3	11690-122I7	36.23	8.27	1.21	0.71	1.01	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	87.75	5.93	0.95	0.59	0.36	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	56.65	3.35	0.56	0.56	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	74.61	5.19	0.47	0.79	0.63	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	48.39	2.69	0.00	1.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.94	5.99	0.95	0.95	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	58.22	4.42	0.32	0.54	0.75	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	65.66	4.51	0.82	1.64	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	57.64	3.29	0.51	0.76	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	60.52	4.64	0.99	0.84	0.84	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	79.11	3.96	0.79	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	57.97	3.88	0.19	0.39	0.00	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	60.17	5.55	0.56	0.19	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	65.16	5.92	0.00	1.05	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	67.50	3.34	0.48	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	60.71	5.22	0.69	0.41	0.69	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	62.52	4.31	1.23	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	55.80	3.74	0.31	1.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	64.96	5.12	0.18	0.37	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	54.96	3.29	1.65	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	68.53	2.64	0.59	0.00	0.88	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	63.23	5.48	0.00	1.49	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	68.38	3.39	0.00	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	66.79	5.92	0.54	1.08	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	62.52	3.63	0.76	0.45	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	49.77	4.15	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	66.38	5.86	0.42	1.05	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	69.92	4.21	0.30	0.45	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	90.11	5.50	0.69	0.69	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	64.72	4.89	0.38	0.75	0.00	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	63.30	5.09	0.42	0.95	0.42	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	71.72	5.81	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	64.83	5.62	0.33	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	66.16	4.34	0.37	1.12	0.87	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	76.63	2.96	0.37	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	62.76	3.71	0.74	1.73	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	58.02	2.89	0.69	0.55	0.55	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	72.37	2.89	0.64	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	80.95	6.09	0.61	0.30	0.00	0.00	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	68.44	5.18	0.28	0.84	0.42	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	66.13	3.91	0.00	1.42	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	80.96	5.82	0.00	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	65.82	4.82	0.62	1.71	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	68.04	5.73	0.72	0.72	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	76.77	4.57	0.00	1.31	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	58.39	2.83	1.18	0.71	0.94	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	106.55	6.06	1.11	0.62	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	80.17	3.84	0.51	0.77	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	65.94	3.58	0.30	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	3.84	1.53	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.78	2.23	0.74	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.77	2.96	1.69	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	22.51	4.92	0.70	0.70	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	26.15	1.87	1.87	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	4.12	0.52	0.00	1.03	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	2.38	0.00	0.00	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	2.49	0.90	0.23	0.90	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.27	2.62	0.58	0.00	0.58	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	1.35	0.45	0.90	0.90	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	23.98	4.34	0.68	0.41	0.41	0.14	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	1.03	2.57	0.51	1.03	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.93	4.23	0.00	1.06	0.35	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	22.65	6.66	0.00	1.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	24.96	6.62	2.04	0.51	0.51	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.35	5.34	0.53	0.27	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	25.51	3.02	0.57	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.70	3.68	0.61	0.61	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	29.36	3.26	1.63	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	26.24	3.33	1.04	0.00	0.42	0.00	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	25.78	4.20	0.28	1.12	0.56	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	2.06	1.03	1.03	0.00	0.00	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	26.42	4.35	0.58	0.87	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.62	2.09	0.90	0.60	0.90	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	25.45	1.66	0.00	1.11	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	33.23	4.95	0.71	1.06	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.23	3.69	1.48	0.37	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	3.45	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.55	1.54	1.54	1.54	0.00	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.91	3.96	0.57	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	2.46	0.00	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.02	3.62	0.90	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	21.54	3.59	0.00	0.00	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	2.99	1.49	0.75	0.00	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.44	3.72	1.11	0.37	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.12	3.45	0.86	0.86	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	0.86	3.43	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.99	3.00	1.33	1.33	0.33	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.37	3.62	0.60	1.21	0.60	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.84	2.84	0.00	2.13	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	3.09	1.03	0.69	0.34	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.62	2.15	0.00	1.61	1.61	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	2.02	0.00	1.35	0.00	1.35	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.00	4.82	0.00	1.85	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	0.00	0.00	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	0.00	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.41	6.00	2.00	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	5.81	0.73	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.96	3.07	0.00	0.00	0.77	0.00	5.37
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.17	3.45	0.00	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	5.65	0.00	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	2.51	0.00	0.50	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	28.84	2.70	0.45	0.00	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	5.16	0.00	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	29.39	4.01	1.78	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.15	4.30	0.00	0.39	0.39	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	5.94	1.32	1.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	3.63	0.52	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.50	2.19	0.00	0.00	0.88	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	34.11	3.91	0.56	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.06	3.09	0.00	0.00	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	5.01	1.93	0.39	0.00	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	26.33	1.52	0.00	0.00	1.01	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	27.88	7.21	0.96	0.48	0.00	0.00	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	35.78	3.58	0.80	1.19	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	36.46	3.04	0.61	0.61	0.61	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	2.08	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	30.02	3.42	1.14	1.14	0.76	0.00	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.57	3.10	0.52	0.52	0.52	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.23	4.84	0.60	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	31.37	5.39	0.63	0.95	0.32	0.00	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.72	5.33	0.00	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.16	1.15	0.00	0.57	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	29.31	2.57	1.54	1.03	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.20	2.83	0.71	1.41	0.00	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	34.62	4.54	0.00	1.13	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.03	4.16	0.00	0.83	0.42	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	3.13	0.00	1.57	2.35	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.23	2.09	0.00	0.84	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	2.79	1.39	0.93	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	2.01	0.00	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.22	1.07	0.53	0.00	0.53	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.56	3.64	2.02	0.81	2.02	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	39.46	0.92	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	52.46	3.56	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	5.13	1.71	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	0.77	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.94	3.28	0.00	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	35.64	5.35	1.34	0.89	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	32.23	5.72	0.78	1.30	0.26	0.00	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.72	2.65	0.00	1.99	0.66	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	35.34	10.39	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	84.56	5.01	0.23	0.68	0.46	2.73	0.00
Macrophage - monocyte derived, donor2	11313-117C8	43.86	5.51	0.18	0.37	0.37	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	54.92	4.33	0.92	0.26	0.00	1.57	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	41.95	6.90	1.06	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	69.09	5.23	0.48	0.16	0.32	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	59.76	6.39	0.00	0.83	0.14	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	32.98	5.48	0.40	1.00	0.00	0.20	0.20
Mammary Epithelial Cell, donor2	11350-117G9	51.54	6.95	0.00	2.32	0.00	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	31.68	4.99	0.25	1.50	0.25	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	14.24	2.71	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	27.58	4.65	0.87	0.32	0.11	0.97	0.11
Mast cell, donor2	11565-120D8	38.63	5.65	0.89	1.19	0.00	0.59	1.19
Mast cell, donor3	11566-120D9	33.99	4.95	1.35	0.90	0.00	0.00	0.45
Mast cell, donor4	11567-120E1	34.57	7.27	1.24	0.00	0.00	0.00	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	34.27	5.32	0.67	1.00	0.00	1.22	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	2.33	2.33	1.17	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	59.54	6.65	1.15	1.15	0.23	1.95	0.57
Mast cell, expanded, donor8	11941-126A6	35.31	5.02	1.34	0.50	0.17	0.84	0.50
Melanocyte - dark, donor1	11502-119F8	119.30	7.96	0.70	1.09	0.40	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	56.76	8.65	0.69	1.38	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	112.86	11.59	1.30	1.59	1.30	1.96	0.36
Melanocyte - light, donor1	11274-116H5	119.42	6.35	0.24	0.47	0.24	1.65	0.47
Melanocyte - light, donor2	11351-117H1	94.18	2.73	0.00	2.73	0.68	1.36	0.00
Melanocyte - light, donor3	11423-118G1	80.65	6.94	1.73	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	148.48	9.16	0.94	1.04	1.35	3.44	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	121.83	7.26	0.81	1.34	1.34	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	115.18	6.43	0.27	0.54	2.41	0.27	0.27
Meningeal Cells, donor1	11493-119E8	125.67	15.14	1.61	1.74	0.50	0.25	0.37
Meningeal Cells, donor2	11573-120E7	69.54	13.64	2.20	0.88	0.44	0.00	0.88
Meningeal Cells, donor3	11654-122E7	86.88	14.67	1.63	2.53	0.57	0.08	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.54	6.27	1.43	1.43	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.01	2.52	0.20	0.40	0.30	0.00	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	2.62	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	2.15	1.44	2.15	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.28	4.24	1.27	0.64	0.42	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	4.52	0.00	1.01	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.34	3.74	1.54	0.44	0.00	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	2.92	1.46	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.32	4.30	1.02	0.41	0.00	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.25	3.46	1.11	0.42	0.14	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.83	5.20	0.37	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	32.89	4.34	0.92	0.26	0.00	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.04	3.56	0.30	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	4.48	0.64	0.00	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.87	4.25	0.35	1.06	0.00	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	31.27	6.25	0.94	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	2.18	0.00	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	18.03	5.57	0.80	0.53	1.33	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	17.52	1.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	16.40	4.48	0.87	0.43	0.29	0.00	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	49.99	3.69	0.74	0.25	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.34	2.36	0.59	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.66	3.41	0.93	0.31	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.26	2.28	0.00	0.21	0.41	0.21	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	4.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	62.06	3.25	0.00	0.75	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	2.79	0.00	1.40	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	58.12	2.24	0.20	0.20	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	42.76	1.19	0.00	0.79	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	54.87	3.54	2.65	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	47.49	2.28	0.38	1.90	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	68.34	2.76	0.42	0.64	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	1.84	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	76.60	3.28	0.30	0.60	0.00	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	3.35	0.00	0.00	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	85.81	3.01	0.25	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	52.29	2.38	0.00	0.71	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	34.28	3.87	1.11	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	114.66	2.30	0.69	0.46	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	71.30	4.42	0.21	0.84	0.00	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	90.91	7.13	1.22	1.02	0.00	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	97.19	4.08	0.00	1.07	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	55.57	3.78	1.11	0.67	0.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	104.69	6.13	0.66	0.22	0.22	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	30.92	1.52	0.00	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	89.69	3.53	0.54	0.54	0.00	1.90	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	62.64	2.35	0.00	0.88	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	34.89	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	103.32	4.81	0.48	0.48	0.96	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	84.45	5.60	0.00	0.00	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	24.68	0.00	0.00	1.37	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	99.61	3.50	0.00	0.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	65.69	2.19	0.00	0.00	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	1.28	0.64	0.00	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	72.39	3.22	0.25	0.25	0.25	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	0.00	0.00	0.70	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	89.57	4.79	0.34	0.68	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	1.75	0.00	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.89	1.42	0.36	0.36	0.00	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	69.30	3.93	0.28	0.28	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.09	2.91	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	22.14	1.75	0.58	0.00	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	65.76	2.71	0.30	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	47.58	3.34	0.83	0.00	0.00	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	49.87	5.54	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	43.82	3.98	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	33.72	5.39	0.14	0.28	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	85.00	2.59	0.26	1.04	0.26	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	34.75	1.29	0.86	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	26.04	0.64	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	54.98	1.60	0.27	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	61.96	4.49	0.30	0.60	0.90	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.90	3.25	0.14	0.28	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	95.24	3.19	0.64	0.00	0.00	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	44.23	3.76	0.00	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.34	1.90	0.38	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	77.28	2.56	0.28	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	59.48	4.18	0.49	0.00	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.72	1.30	0.65	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	63.51	4.41	0.59	0.29	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	72.95	3.17	0.29	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	47.81	4.12	0.00	2.06	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	70.87	3.87	0.00	1.49	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	5.35	0.00	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	103.50	2.96	0.33	0.66	0.00	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	73.64	3.16	0.00	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	73.14	4.94	0.40	0.20	0.40	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	88.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	90.13	1.88	0.00	0.75	0.38	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	66.05	4.26	0.00	0.53	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	63.56	2.71	0.11	0.11	0.23	1.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	61.15	3.68	0.74	0.74	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	91.24	4.40	0.00	0.00	0.37	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	74.67	1.56	0.00	0.00	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	1.07	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	88.87	1.01	2.02	2.02	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.24	0.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	6.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	0.00	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.68	1.94	0.22	0.22	0.22	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	3.14	2.09	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	1.33	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.92	0.83	0.42	0.42	0.00	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5.51	1.14	0.19	0.57	0.19	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	3.19	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	0.84	0.42	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.51	1.86	0.23	0.23	0.00	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	3.51	0.27	0.54	0.00	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.77	2.73	0.00	0.21	0.00	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	1.49	0.50	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.99	3.25	0.00	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.71	0.91	0.00	0.23	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.49	1.80	0.98	0.00	0.16	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.84	2.37	0.18	0.55	0.36	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	3.18	0.00	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	0.60	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.44	1.31	0.00	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	0.98	0.00	0.00	0.33	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.11	1.41	0.00	0.18	0.00	0.18	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	1.41	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.87	2.30	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.35	2.25	0.32	0.00	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.55	0.69	0.00	0.34	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.58	1.78	0.45	0.22	0.22	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	1.69	0.42	0.00	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.21	1.19	0.47	0.24	0.24	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	1.72	0.86	1.29	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.33	2.00	0.33	0.33	0.00	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.92	2.25	0.00	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.51	1.19	0.40	0.00	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	1.86	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.84	0.76	0.38	0.76	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	1.63	0.00	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.05	1.74	0.44	0.00	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	9.05	0.90	0.00	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	0.88	0.00	0.88	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	2.66	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	2.98	0.00	0.50	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	1.15	0.38	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.01	4.54	0.91	0.60	0.60	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.18	1.55	0.22	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	3.39	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	0.61	0.00	0.61	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.52	0.94	0.31	0.00	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	1.21	0.00	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	2.37	0.79	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	0.00	0.00	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	5.22	1.37	0.12	0.00	0.62	0.25	0.25
Myoblast, donor2	11322-117D8	3.84	1.73	0.77	0.38	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	6.05	2.02	0.34	0.17	0.17	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	33.42	3.50	0.44	0.29	0.00	1.46	0.00
Natural Killer Cells, donor1	11230-116C6	100.25	3.08	1.54	0.00	0.00	2.46	1.23
Natural Killer Cells, donor2	11311-117C6	100.72	6.63	0.00	0.90	0.00	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	96.44	6.81	0.74	0.74	0.18	1.10	1.10
Neural stem cells, donor1	11275-116H6	160.42	23.23	3.27	6.17	0.73	0.00	1.09
Neural stem cells, donor2	11352-117H2	84.73	15.41	9.63	5.78	1.93	0.00	9.63
Neurons, donor1	11494-119E9	18.21	9.10	5.69	0.00	9.10	0.00	1.14
Neurons, donor2	11574-120E8	27.74	11.45	6.38	1.32	4.40	0.00	3.96
Neurons, donor3	11655-122E8	15.62	7.40	2.47	0.82	4.11	0.00	3.29
Neutrophils, donor1	11233-116C9	77.02	4.64	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	78.27	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	109.34	3.05	0.61	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	40.25	8.19	1.54	1.54	0.00	0.00	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	21.82	2.28	0.65	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.65	4.21	0.20	1.20	0.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	19.27	2.48	0.28	0.41	0.41	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	18.96	2.89	0.43	0.43	0.72	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	15.32	3.06	0.34	0.34	0.23	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	14.61	3.70	1.46	0.29	0.00	0.10	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	67.40	10.23	2.41	1.20	0.00	0.00	2.41
Osteoblast - differentiated, donor1	11276-116H7	6.59	0.85	0.64	0.21	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	1.14	1.14	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	12.41	2.48	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	10.36	3.91	0.98	0.98	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	13.34	2.11	0.70	0.00	0.00	0.00	1.40
Osteoblast, donor3	11426-118G4	11.20	4.44	0.89	0.18	0.36	0.00	1.07
Pancreatic stromal cells, donor1	11249-116E7	21.65	4.21	0.51	0.42	0.34	0.08	0.08
Pericytes, donor1	11491-119E6	89.12	11.35	1.34	0.89	0.78	0.33	1.11
Pericytes, donor2	11571-120E5	57.04	7.70	1.58	1.36	0.00	0.00	1.36
Pericytes, donor3	11652-122E5	24.62	2.44	0.61	0.00	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	33.91	5.88	0.90	0.23	0.23	0.00	0.34
Perineurial Cells, donor2	11579-120F4	65.42	7.91	0.83	1.75	0.55	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	138.97	4.78	0.64	1.27	0.00	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	116.31	3.67	1.47	0.00	0.49	1.71	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	108.32	7.51	1.42	1.16	0.00	1.94	0.52
Placental Epithelial Cells, donor1	11278-116H9	28.46	4.30	1.20	0.48	0.00	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	35.48	4.44	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	31.02	5.89	1.18	0.79	0.39	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.28	2.53	0.00	0.32	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	7.13	1.69	0.00	0.56	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.09	1.44	0.65	0.26	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	6.08	0.90	0.23	1.13	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	9.59	1.70	0.64	0.43	0.00	0.00	0.32
Preadipocyte - omental, donor2	11329-117E6	7.42	2.18	0.44	0.44	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	7.02	2.01	0.43	0.14	0.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	6.89	1.97	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	28.87	4.61	1.54	1.54	0.00	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	55.07	8.50	0.35	2.30	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	24.35	2.38	0.85	0.34	0.51	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	34.56	5.31	0.65	0.84	0.19	0.00	0.65
Preadipocyte - visceral, donor2	11357-117H7	58.90	10.58	0.92	1.38	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	25.29	5.22	0.31	0.10	0.00	0.21	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	89.15	8.00	1.06	0.91	0.00	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	56.33	5.42	0.41	0.95	0.54	0.41	0.54
Prostate Epithelial Cells, donor3	11404-118D9	36.07	4.29	0.55	0.67	0.12	0.31	0.49
Prostate Stromal Cells, donor1	11254-116F3	12.53	2.62	0.34	0.46	0.23	0.00	0.23
Prostate Stromal Cells, donor2	11332-117E9	23.85	3.59	0.36	0.36	0.18	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	13.87	2.61	0.31	0.52	0.10	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	126.65	10.95	1.09	0.73	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	134.88	12.96	0.55	1.25	0.49	0.69	0.42
Renal Epithelial Cells, donor1	11517-119H5	95.87	15.72	0.51	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	118.79	14.23	2.13	1.42	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	170.02	19.80	1.69	1.69	1.91	0.00	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	134.13	8.17	2.04	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	144.60	8.49	0.67	1.62	0.27	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	69.93	5.11	0.22	0.67	0.89	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	63.88	3.33	2.66	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	96.62	13.43	1.98	0.22	0.44	0.00	1.10
Renal Mesangial Cells, donor2	11598-120H5	104.71	13.17	3.13	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	68.24	11.10	2.22	1.11	0.28	0.00	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	165.08	9.93	1.07	2.15	1.34	1.88	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	113.44	9.70	1.27	1.27	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	123.04	16.20	2.31	2.51	0.58	0.77	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.45	7.52	0.78	1.04	0.00	0.00	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.80	6.54	0.85	1.71	0.28	0.00	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	38.08	5.15	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.36	2.51	0.25	0.75	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	72.56	6.15	0.67	0.53	0.13	0.67	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	23.23	0.89	0.89	0.00	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	2.75	0.00	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	1.74	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.52	1.69	0.00	0.00	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	14.40	2.88	0.70	0.30	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.07	3.46	1.00	0.00	0.45	0.11	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.11	1.98	0.62	0.25	0.12	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.76	3.85	0.58	1.05	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.49	5.08	0.46	0.23	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.96	0.68	0.27	0.27	0.41	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.03	1.97	0.91	0.00	0.00	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.77	4.30	0.18	0.72	0.18	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.50	2.58	0.57	0.43	0.43	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	14.38	2.58	0.64	0.64	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.91	3.98	0.44	0.66	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.76	2.10	0.38	0.19	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.67	3.54	0.19	0.37	0.28	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.23	3.57	0.56	0.38	0.38	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.75	1.06	0.40	0.00	0.40	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.02	2.73	1.07	0.29	0.29	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.94	3.82	0.57	0.57	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.07	1.82	0.43	0.21	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.42	3.36	0.56	0.28	0.00	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	13.50	1.88	0.34	0.17	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.40	1.64	0.00	0.00	0.36	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.49	2.94	0.61	0.37	0.25	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.58	4.16	0.94	0.81	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.99	1.18	0.00	0.47	0.47	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.51	2.98	0.40	0.40	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.86	1.87	0.94	0.23	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.38	1.87	0.21	0.62	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.50	1.55	0.88	0.00	0.88	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.79	3.13	0.00	0.42	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.15	1.62	0.00	0.54	0.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	7.15	1.70	0.34	0.17	0.00	0.00	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.34	1.74	0.19	0.39	0.00	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.02	2.41	0.34	0.00	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.50	1.65	0.27	0.41	0.27	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	11.66	1.97	0.49	0.49	0.49	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	16.19	2.05	0.34	0.17	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.35	3.85	0.89	0.15	0.15	0.00	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	12.79	1.87	0.53	0.27	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.73	2.63	0.00	0.69	0.14	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.10	4.29	1.19	0.95	0.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	19.95	4.84	0.40	0.40	0.20	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.45	3.11	0.75	0.19	0.38	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.56	3.84	0.70	1.05	0.70	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	11.48	4.53	0.30	0.00	0.00	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.99	1.71	0.24	0.61	0.49	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	23.87	5.53	0.87	0.44	0.44	0.15	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.73	2.43	0.61	0.61	0.61	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.91	3.62	0.60	0.30	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.39	4.30	1.13	0.45	0.00	0.00	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.16	5.09	1.50	0.60	0.00	0.00	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.72	2.13	0.59	0.35	0.35	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.51	2.56	0.85	1.07	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	2.40	2.40	1.20	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	47.39	6.58	1.13	0.56	0.00	0.00	1.13
Schwann Cells, donor2	11578-120F3	68.05	20.41	3.40	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	67.04	7.23	1.97	0.88	0.66	0.00	0.44
Sebocyte, donor1	11220-116B5	97.50	22.46	2.19	0.55	0.00	1.10	0.55
Sebocyte, donor2	11301-117B5	65.72	6.43	0.92	0.46	0.00	2.30	0.00
Sebocyte, donor3	11378-118B1	31.95	7.01	0.62	0.41	0.00	2.06	0.41
Sertoli Cells, donor1	11255-116F4	21.54	6.63	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	8.47	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.88	7.48	1.06	1.50	0.35	0.00	0.35
Skeletal Muscle Cells, donor2	11358-117H8	10.12	2.17	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	17.56	8.36	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	29.38	5.03	0.94	0.79	0.00	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	28.69	5.05	0.89	0.30	0.00	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	22.93	5.39	0.92	0.62	0.00	0.00	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.50	5.80	1.26	1.13	0.13	0.00	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.54	4.99	1.71	0.57	0.29	0.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.57	5.16	0.69	0.79	0.20	0.10	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.80	6.07	1.60	0.51	0.51	0.25	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	22.44	5.07	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	31.79	5.09	1.51	0.41	0.41	0.00	0.28
Skin - palm, donor1	10286-104F7	21.49	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.71	3.17	0.29	0.43	0.29	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	108.78	4.09	0.00	1.64	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.41	2.60	0.65	0.00	0.00	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	46.01	4.45	0.00	0.28	0.14	0.97	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	26.44	2.39	0.84	0.00	0.00	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	63.22	7.82	1.27	0.42	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	21.74	2.77	0.60	0.52	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.17	1.54	0.00	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.45	4.89	0.44	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	1.76	0.00	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.25	4.42	0.44	1.33	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.59	3.94	0.79	1.18	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	4.64	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	2.00	2.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.98	2.53	0.40	0.53	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.06	4.21	0.66	1.11	0.00	0.44	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.53	0.64	0.26	0.38	0.26	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.02	5.86	0.65	0.65	0.00	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.40	4.13	0.59	0.59	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.66	3.42	0.71	0.71	0.43	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.75	5.21	0.49	0.81	0.49	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	31.05	4.57	1.22	0.61	0.00	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.76	9.60	1.26	1.26	0.76	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	1.91	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.06	4.57	0.15	0.29	0.15	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.69	2.80	0.65	0.65	0.00	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.43	4.20	0.31	0.63	0.10	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.95	5.41	0.62	0.31	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	3.23	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	71.43	6.28	0.60	1.20	0.60	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.07	6.49	0.68	0.34	0.34	0.00	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.78	4.79	0.79	0.55	0.24	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.94	1.41	0.60	0.10	0.10	0.00	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	2.96	1.37	0.68	0.23	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	33.81	1.21	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	23.58	4.24	0.26	0.53	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	19.31	2.66	0.40	0.80	0.00	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.14	1.63	0.50	0.63	0.00	0.00	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.56	4.31	0.00	1.01	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	24.73	5.73	0.90	0.45	0.45	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	2.25	0.00	0.75	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	108.55	3.88	0.00	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.11	6.05	0.93	0.47	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	2.02	0.50	0.00	0.50	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.27	0.63	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.89	5.01	0.29	0.88	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.74	4.67	0.58	0.67	0.00	0.00	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	3.74	0.93	1.40	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.84	3.17	0.43	0.14	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.95	3.82	0.25	1.02	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.91	4.89	0.75	0.38	0.56	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.06	6.29	1.12	0.42	0.14	0.14	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	32.26	6.37	0.50	0.25	0.08	0.08	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.71	3.33	0.00	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.88	3.67	0.00	0.24	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.07	2.87	0.00	0.66	0.66	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.70	1.76	0.88	1.17	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.11	2.53	0.78	0.19	0.00	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.70	1.06	0.26	0.00	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	1.12	0.00	0.37	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.19	0.72	0.00	0.00	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.26	0.28	0.00	0.00	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.06	1.58	0.00	0.00	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	6.86	1.02	0.25	0.25	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	9.18	2.40	0.40	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	1.67	0.00	0.42	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	10.27	3.03	0.50	0.34	0.00	0.00	0.50
Synoviocyte, donor2	11368-117I9	11.23	3.35	0.84	0.34	0.00	0.00	0.17
Synoviocyte, donor3	11440-118H9	13.63	2.23	0.45	0.00	0.00	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	187.60	20.73	1.07	1.43	0.00	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	67.61	10.19	0.93	0.93	0.23	0.23	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	43.23	5.38	0.22	0.43	0.07	0.50	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	39.43	7.73	1.16	0.00	0.00	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	40.66	5.73	0.00	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	72.83	6.27	1.48	0.62	0.12	0.98	0.86
Urethra, donor2	10319-105A4	25.18	0.00	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	99.89	11.42	0.80	1.33	0.53	2.39	0.00
Urothelial Cells, donor2	11600-120H7	76.11	10.41	0.40	1.60	0.80	2.00	0.80
Urothelial Cells, donor3	11681-122H7	72.66	6.65	0.92	0.23	0.00	1.15	0.23
Urothelial cells, donor0	11216-116B1	118.58	10.25	0.45	0.89	0.22	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	143.26	8.90	0.89	0.00	0.89	4.45	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	150.11	11.44	1.43	0.00	0.00	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	101.31	6.85	0.68	0.00	0.00	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	101.92	5.85	1.03	2.75	0.00	1.72	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	98.77	4.65	0.58	0.00	0.00	3.49	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	165.56	1.04	2.08	2.08	0.00	3.12	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	157.86	6.42	0.00	0.92	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	112.29	10.04	1.83	0.00	0.00	5.48	0.91
Wilms' tumor cell line:G-401	10809-111A8	7.28	3.08	0.99	0.37	0.12	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	14.08	0.88	0.88	0.00	0.00	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	52.23	6.70	0.56	0.28	0.00	0.84	1.12
achilles tendon, donor2	10292-104G4	37.20	0.00	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.73	2.29	0.51	0.76	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.63	3.02	1.16	0.00	0.00	0.23	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.24	4.51	1.19	0.59	0.00	0.00	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.30	5.99	3.27	1.36	0.00	1.36	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.87	3.09	0.56	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	53.93	8.67	2.11	0.63	0.63	0.63	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.00	4.36	0.54	2.18	0.00	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.69	1.76	1.76	0.88	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.15	4.08	1.23	0.00	0.00	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	31.84	3.49	1.16	1.16	0.00	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	73.78	5.70	0.37	0.18	0.37	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.03	4.42	0.93	0.00	0.23	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	9.58	3.11	0.52	0.26	0.78	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.24	2.63	0.00	0.58	0.00	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	1.39	0.93	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	53.87	2.88	0.82	0.41	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.35	1.53	0.31	0.00	0.61	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.88	4.27	0.43	1.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.69	3.64	0.30	0.61	0.30	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.85	4.33	0.96	0.48	0.48	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	35.86	2.45	0.22	0.45	0.45	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.68	2.33	0.00	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	16.72	1.86	0.00	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	50.85	6.03	1.88	1.13	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1.31	1.31	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	7.50	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	24.02	5.42	0.24	0.71	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	128.59	3.72	0.47	0.31	0.16	0.62	0.16
adipose, donor1	10184-103D4	26.97	5.86	1.17	2.93	0.00	0.00	1.17
adipose, donor2	10185-103D5	12.98	6.08	1.22	0.81	0.00	0.00	1.62
adipose, donor3	10186-103D6	33.76	4.36	3.27	1.63	0.82	0.00	1.63
adipose, donor4	10187-103D7	65.87	7.80	3.47	1.73	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.63	2.84	1.74	0.00	0.16	0.00	1.74
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	0.00	0.00	0.00	0.00	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	57.63	7.47	2.00	1.20	0.13	0.93	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	275.84	26.80	1.79	5.36	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	36.63	6.26	1.16	0.93	0.00	0.93	0.46
amniotic membrane cells, donor2	12236-129G4	21.64	4.40	1.69	0.00	0.34	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	8.54	0.88	0.29	0.29	0.59	0.00	0.29
amygdala - adult, donor10196	10167-103B5	20.16	1.19	0.00	0.00	9.49	0.00	0.00
amygdala, adult, donor10252	10151-102I7	34.27	4.66	1.22	0.41	8.72	0.20	2.43
amygdala, newborn, donor10223	10360-105E9	19.69	4.52	1.94	0.00	14.52	0.00	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	17.32	2.04	0.38	0.25	0.00	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2.21	0.66	0.22	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.37	8.35	0.33	1.34	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	26.09	3.92	0.78	0.20	0.00	0.20	0.20
appendix, adult	10189-103D9	35.32	4.27	1.16	0.39	0.00	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	20.29	1.72	0.00	0.00	2.06	0.00	0.00
artery, adult	10190-103E1	23.10	2.72	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	39.11	7.82	1.59	0.58	1.59	0.72	1.16
b cell line:RPMI1788	10427-106D4	17.40	4.91	0.45	0.15	0.00	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.05	1.94	0.83	0.83	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.27	3.18	0.99	0.30	0.20	0.40	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	51.05	3.35	0.17	1.00	0.17	1.17	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	2.80	1.12	0.00	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	35.31	3.59	0.54	0.33	0.11	0.22	0.65
blood, adult, pool1	10053-101G8	115.16	2.21	0.00	2.21	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	3.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	90.43	9.45	0.67	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	21.53	8.20	1.03	0.00	6.15	1.03	1.03
brain, adult, pool1	10012-101C3	17.37	2.78	1.22	0.11	4.34	0.00	1.56
brain, fetal, pool1	10085-102B4	34.73	26.71	5.34	0.00	42.74	0.00	8.01
breast carcinoma cell line:MCF7	10482-107A5	18.17	3.96	0.66	0.33	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.72	4.49	0.62	0.75	0.12	0.00	0.75
breast, adult, donor1	10080-102A8	79.55	5.68	0.63	0.63	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	33.16	5.97	1.65	1.27	0.13	0.13	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	4.33	1.24	0.31	0.00	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.76	4.14	1.38	0.69	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	19.61	4.60	0.24	0.24	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.05	3.29	0.00	2.35	0.94	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	12.69	2.63	0.11	0.22	0.00	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	6.34	5.70	0.63	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	30.08	5.59	2.13	0.80	0.53	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	39.14	1.15	1.15	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	23.26	5.19	1.00	0.17	2.18	0.00	1.67
caudate nucleus, adult, donor10258	10379-105H1	12.23	0.76	1.53	0.00	4.58	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	26.00	1.83	0.37	0.73	2.56	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	17.48	0.00	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	20.92	1.92	0.85	0.21	0.21	0.43	0.43
cerebellum, adult, pool1	10083-102B2	9.31	1.38	0.34	0.00	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	22.42	4.98	1.66	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	8.82	2.02	0.76	0.00	6.81	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	13.89	0.73	0.00	0.00	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	2.44	0.72	0.00	0.29	0.00	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	134.73	9.28	1.16	0.83	0.33	5.30	0.33
cervix, adult, pool1	10013-101C4	49.87	5.35	0.84	0.94	0.00	0.52	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	5.71	2.37	1.11	0.42	0.14	0.00	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.23	6.71	2.11	0.75	0.12	0.12	0.87
choriocarcinoma cell line:SCH	10785-110H2	7.76	1.85	0.49	0.25	0.00	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	8.54	2.61	0.47	0.47	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	51.29	5.70	0.57	0.57	1.14	0.00	1.14
chorionic membrane cells, donor2	12239-129G7	77.66	8.35	0.70	1.49	0.30	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	86.27	10.44	1.65	1.10	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.75	3.65	1.15	1.34	0.38	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.41	5.70	0.84	0.63	0.00	0.63	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	58.29	8.73	1.80	2.57	0.26	0.26	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	63.86	7.26	0.73	1.21	0.00	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	54.16	9.57	1.63	1.22	0.41	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	66.84	10.89	1.18	1.47	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.96	10.43	0.26	0.78	0.00	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.00	6.17	1.83	0.23	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	38.87	1.91	0.52	0.52	0.00	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	72.30	7.32	1.10	0.73	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	14.82	4.56	0.76	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	41.65	4.76	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	34.90	3.64	0.47	0.47	0.00	0.35	0.12
colon, fetal, donor1	10070-101I7	37.70	6.80	1.24	1.24	0.00	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	36.67	9.17	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1.70	0.42	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.92	1.21	0.75	0.15	0.00	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	5.50	0.99	0.56	0.14	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	43.34	5.75	1.22	0.88	1.11	0.11	2.54
cruciate ligament, donor2	10295-104G7	40.52	2.43	0.81	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	33.71	4.01	0.00	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	14.88	1.68	0.24	0.00	1.68	0.00	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.97	2.53	0.00	0.92	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	35.90	4.10	0.51	0.51	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.50	3.13	0.72	1.20	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	68.27	6.98	1.00	1.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	48.97	5.76	1.44	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	51.50	5.15	0.74	2.21	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	74.49	5.62	0.74	0.33	0.33	0.25	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.55	0.89	0.22	0.00	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	12.47	3.44	0.43	1.00	0.00	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	59.20	4.93	1.23	0.62	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	86.27	12.11	1.82	1.21	0.30	0.30	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	47.24	6.48	1.23	0.62	0.00	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	94.57	6.57	1.31	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	20.11	1.68	0.34	0.67	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.96	5.80	2.54	0.54	0.18	0.00	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.62	7.24	0.96	0.96	0.64	0.64	0.48
epidermoid carcinoma cell line:A431	10426-106D3	34.01	4.45	0.00	0.44	0.00	1.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.25	5.17	0.88	0.44	0.00	0.11	0.44
epididymis, adult	10197-103E8	53.16	5.44	0.42	1.47	0.21	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	2.31	1.60	1.06	0.89	0.18	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.18	0.00	0.39	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.15	1.44	0.39	0.92	0.13	0.00	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.61	0.69	0.20	0.59	0.10	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	11.99	1.34	0.22	0.34	0.11	0.00	0.22
esophagus, adult, pool1	10015-101C6	47.99	5.52	0.53	0.74	0.00	2.44	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.63	1.25	0.75	0.00	0.13	0.00	0.38
eye - muscle inferior rectus, donor1	10272-104E2	28.97	0.00	0.00	4.83	0.00	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	27.35	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	4.59	0.00	1.15	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	1.46	0.00	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	44.75	4.32	0.76	0.76	0.76	1.53	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	28.08	5.00	0.77	1.03	0.26	0.13	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.71	4.51	0.71	0.95	0.00	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	16.23	3.57	0.66	0.47	12.67	0.09	1.69
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	51.94	4.80	0.60	0.00	0.30	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.05	2.93	0.73	0.46	0.09	0.09	0.27
gall bladder, adult	10198-103E9	28.73	4.59	0.48	1.21	0.24	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	153.54	10.20	0.54	1.07	0.00	4.29	0.00
gamma delta positive T cells, donor2	11938-126A3	154.25	6.72	1.12	1.12	0.00	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.24	0.63	0.21	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.34	3.48	0.39	0.97	0.00	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	7.21	3.77	1.48	0.66	0.00	0.00	0.49
gastric cancer cell line:GSS	10560-108A2	9.15	4.58	3.66	3.66	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	2.51	0.91	1.37	0.46	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	1.03	0.46	0.00	0.11	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	42.41	14.14	1.12	0.56	0.28	0.42	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.18	2.49	1.00	0.50	0.00	2.99	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.05	4.43	0.32	0.32	0.21	0.00	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.87	3.23	1.12	0.56	0.14	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	8.28	2.43	0.22	0.33	0.11	0.00	0.00
glioma cell line:GI-1	10413-106B8	27.82	5.27	0.29	0.00	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	31.34	3.64	0.00	0.00	2.19	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	53.46	4.15	1.46	0.24	0.00	0.24	1.71
globus pallidus, adult, donor10258	10367-105F7	20.54	1.37	1.37	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	24.51	2.13	1.07	0.53	1.60	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	2.45	2.45	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.16	3.20	0.32	0.00	0.00	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	28.01	4.13	0.00	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	37.50	0.91	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	28.98	2.58	0.00	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	30.18	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.89	2.74	0.00	1.37	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	19.86	1.10	0.00	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	19.25	5.75	0.29	0.00	0.00	0.00	0.57
heart - mitral valve, adult	10205-103F7	29.60	5.08	0.60	0.90	0.00	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	27.72	3.92	0.26	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	42.46	4.16	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	39.18	5.71	1.43	0.20	0.20	1.02	1.22
heart, adult, diseased, donor1	10051-101G6	38.75	1.70	0.43	0.00	0.00	1.70	0.43
heart, adult, pool1	10016-101C7	28.98	2.07	0.69	0.23	0.00	0.69	0.23
heart, fetal, pool1	10046-101G1	77.83	7.50	1.44	0.72	0.10	0.41	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.11	4.94	1.54	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	3.57	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	72.15	7.85	0.99	1.33	0.22	0.00	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	74.16	8.98	0.85	1.09	0.24	0.00	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	83.07	9.50	1.11	0.91	0.40	0.00	0.51
hepatoma cell line:Li-7	10484-107A7	13.46	2.56	0.67	0.56	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.05	0.90	0.50	0.10	0.00	0.60	0.30
hippocampus - adult, donor10196	10169-103B7	34.07	2.84	1.89	0.00	4.73	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	37.76	4.08	2.65	0.41	5.92	0.00	0.82
hippocampus, adult, donor10258	10374-105G5	17.43	1.99	1.00	0.00	10.95	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	20.44	3.17	0.70	0.35	7.40	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	27.47	6.71	2.44	1.22	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	23.96	7.66	1.18	0.98	0.00	0.00	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.17	5.84	2.03	0.00	0.00	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.29	7.89	2.26	1.13	1.13	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.08	9.81	4.39	4.39	0.26	0.26	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	39.48	12.91	4.56	3.42	0.38	0.00	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.20	8.47	2.92	1.46	0.58	0.00	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	33.82	8.19	2.15	1.72	0.22	0.22	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	42.12	4.59	1.25	0.83	0.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	42.62	8.52	3.08	1.18	0.95	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.50	8.36	2.57	1.45	0.96	0.00	1.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	31.65	10.10	0.67	2.02	1.35	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.04	4.85	0.94	1.41	0.16	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.55	3.44	0.98	1.97	0.49	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	26.18	2.62	0.87	3.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	37.61	7.45	2.29	1.53	0.38	0.00	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.47	8.72	0.87	0.87	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	5.50	1.50	1.00	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.56	3.96	1.32	1.88	0.38	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.92	3.18	1.82	1.82	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.79	1.88	1.25	0.31	0.63	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.80	4.57	0.82	1.47	0.16	0.00	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.87	4.06	1.45	0.00	0.00	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	14.35	2.09	1.20	0.60	0.90	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.94	6.28	0.37	1.85	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.25	5.14	0.57	1.14	0.29	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.03	6.12	1.22	1.63	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	26.41	9.51	1.76	0.35	0.35	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.09	8.24	1.58	1.27	0.32	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	32.99	6.96	2.12	1.21	0.61	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	7.24	0.52	0.52	0.00	0.00	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	7.31	1.99	0.00	0.00	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.63	4.10	2.05	1.03	0.00	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.08	5.88	0.77	1.02	1.28	0.00	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	28.77	4.54	0.00	0.00	0.76	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.54	2.35	0.67	1.34	1.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	21.49	5.31	1.21	1.21	0.00	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	26.29	3.57	0.89	0.89	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.22	6.83	1.46	1.46	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.42	10.09	1.22	1.83	0.31	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	13.01	3.25	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	35.41	8.60	1.65	1.32	0.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.69	7.11	1.09	1.64	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.50	5.43	0.36	0.00	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.18	7.83	2.14	0.71	0.71	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	29.83	5.97	2.39	0.00	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	41.17	9.07	1.76	1.08	0.81	0.00	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.87	4.85	1.62	0.81	0.54	0.00	1.08
immature langerhans cells, donor1	11904-125F5	2.91	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	17.43	3.17	0.79	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	16.84	3.12	1.61	0.38	14.86	0.00	3.03
keratoacanthoma cell line:HKA-1	10791-110H8	49.75	4.23	0.65	1.63	0.00	0.33	0.33
kidney, adult, pool1	10017-101C8	52.97	5.71	0.50	0.80	0.00	0.00	0.90
kidney, fetal, pool1	10045-101F9	74.98	10.19	1.20	0.99	0.50	0.07	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	3.12	1.56	0.85	0.14	0.00	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.28	2.35	0.55	0.28	0.14	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.70	1.47	0.00	0.00	0.00	0.00	0.55
left atrium, adult, donor1	10079-102A7	33.24	2.18	0.54	0.00	0.54	0.00	1.09
left ventricle, adult, donor1	10078-102A6	34.38	2.53	0.00	0.51	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	3.01	2.19	0.27	0.27	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	17.24	3.95	0.36	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	32.07	4.89	0.54	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	13.84	2.19	0.97	0.73	0.00	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	2.09	0.00	2.09	0.00	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.26	3.66	0.59	0.83	0.24	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	9.06	1.87	0.47	0.47	0.00	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	26.44	2.92	0.12	0.00	0.49	0.37	0.12
liver, adult, pool1	10018-101C9	29.98	1.62	0.32	0.16	0.00	0.00	0.16
liver, fetal, pool1	10086-102B5	40.45	3.76	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	23.92	1.90	0.44	0.29	0.15	0.00	1.46
locus coeruleus, adult, donor10252	10165-103B3	35.62	3.69	0.18	0.55	1.11	0.00	1.11
locus coeruleus, adult, donor10258	10375-105G6	14.39	2.26	0.00	0.00	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	23.13	3.36	0.00	0.00	0.84	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	38.47	3.74	0.28	0.83	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	0.69	0.00	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	4.22	2.37	1.19	0.13	0.26	0.26	0.53
lung, adult, pool1	10019-101D1	74.30	5.55	0.47	0.83	0.12	1.30	0.35
lung, fetal, donor1	10068-101I5	210.35	9.70	2.00	0.29	0.00	0.57	1.43
lung, right lower lobe, adult, donor1	10075-102A3	63.69	5.50	0.00	0.92	0.00	0.92	2.29
lymph node, adult, donor1	10077-102A5	87.57	2.84	0.00	0.00	0.00	3.31	0.47
lymphangiectasia cell line:DS-1	10727-110A7	32.88	4.16	0.22	0.44	0.00	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.32	1.66	0.45	0.45	0.00	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	0.00	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	61.27	2.66	0.89	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	67.45	2.70	0.21	1.25	0.42	0.00	0.62
mature adipocyte, donor3	12233-129G1	73.73	2.61	0.24	0.47	0.24	0.24	0.00
mature adipocyte, donor4	12234-129G2	81.07	3.16	0.26	0.79	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.44	3.34	0.95	0.24	0.00	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	2.26	1.13	1.13	6.77	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	30.53	3.49	1.10	0.00	5.52	0.18	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	11.75	1.27	0.64	0.32	6.35	0.00	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	31.13	4.26	1.28	0.85	20.90	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	22.28	3.04	0.68	0.34	9.96	0.00	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	31.83	4.24	0.42	0.42	9.34	0.00	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	1.93	1.93	0.00	15.41	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	37.33	6.10	1.44	0.36	31.94	0.00	1.79
medulla oblongata - adult, donor10196	10174-103C3	36.99	0.65	0.00	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	42.42	4.49	0.77	0.77	0.46	0.62	1.24
medulla oblongata, adult, pool1	10038-101F2	40.98	3.59	0.65	0.73	0.57	0.16	1.14
medulla oblongata, newborn, donor10223	10361-105F1	31.25	2.78	0.69	0.69	0.35	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	27.68	8.86	0.89	1.11	1.55	0.00	0.66
medulloblastoma cell line:ONS-76	10759-110E3	21.52	4.89	0.61	0.86	0.00	0.00	0.86
melanoma cell line:COLO 679	10514-107E1	203.83	12.51	1.01	3.02	2.59	5.17	0.14
melanoma cell line:G-361	10465-106H6	24.43	3.26	0.54	0.27	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	12.66	2.89	0.54	0.54	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	31.72	10.57	2.64	1.76	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	33.70	10.63	2.59	2.07	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.63	3.22	0.31	0.46	0.15	0.00	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.90	3.27	0.73	0.36	0.18	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.17	4.14	0.00	1.66	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.82	3.23	0.28	0.28	0.14	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.52	3.66	0.77	0.77	0.58	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	45.81	2.08	0.00	0.69	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	25.92	3.95	0.34	0.51	0.00	0.00	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.30	4.60	0.58	0.69	0.12	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.03	4.24	0.40	0.66	0.13	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.56	3.78	1.22	0.54	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	82.09	8.96	1.42	1.00	0.57	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	58.95	3.62	1.32	0.66	0.33	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	44.14	7.20	1.11	1.52	0.28	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.24	0.35	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.19	3.27	0.61	0.41	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	55.36	2.88	1.80	1.08	0.00	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.79	2.69	0.72	0.41	0.21	0.00	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.96	2.05	0.46	0.23	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	38.60	5.45	0.00	0.00	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.76	6.58	0.75	0.90	0.30	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	36.59	5.25	0.53	1.49	0.53	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	52.65	7.73	1.10	0.00	0.37	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	48.36	6.58	0.00	0.57	0.86	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	12.63	3.79	0.84	0.42	0.00	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	0.46	0.00	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.51	2.56	1.02	0.26	0.00	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.16	4.97	1.31	0.26	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.48	1.54	0.62	0.31	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.71	1.41	0.47	0.24	0.00	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.45	2.03	0.68	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	10.22	2.75	1.96	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	2.78	0.93	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	2.02	0.58	0.58	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.71	1.56	0.89	0.00	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.46	0.96	0.00	0.48	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.87	0.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.73	2.01	0.34	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.56	1.64	0.82	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	2.15	0.00	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	2.73	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.72	1.30	0.97	0.65	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.59	1.07	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	1.64	0.00	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	1.55	0.00	0.78	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	0.00	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	15.42	1.19	0.00	0.00	0.59	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	3.66	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	0.00	0.00	0.63	0.63	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.00	2.41	0.00	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	34.63	2.04	0.00	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	3.18	0.79	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	64.85	3.54	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	60.16	5.92	0.00	0.94	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	76.19	12.03	2.67	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	96.98	4.73	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	97.58	5.14	2.57	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	97.06	0.69	0.00	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	128.16	4.45	0.49	0.99	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	108.79	6.73	0.00	1.12	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	130.39	7.00	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	120.49	3.22	0.81	1.21	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	122.11	10.90	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	106.43	3.80	0.00	2.53	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	103.78	3.64	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	94.90	0.00	0.00	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	91.43	5.77	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.50	3.37	0.79	0.00	0.40	0.20	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	70.09	4.22	0.00	0.65	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	67.23	6.11	0.00	1.02	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	0.77	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.59	4.96	0.94	0.24	0.00	0.47	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.29	3.94	1.16	0.23	0.00	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	0.00	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.32	1.75	0.31	0.21	0.72	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	24.06	1.13	0.23	0.23	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	25.91	3.18	0.49	0.00	0.24	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	40.96	4.43	1.11	0.66	0.44	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	17.87	1.58	0.53	0.26	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	23.15	3.06	0.51	0.00	0.34	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	20.22	4.04	0.51	0.51	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	10.15	2.48	0.41	0.21	0.00	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	74.38	5.47	1.33	1.33	0.33	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	41.81	5.97	0.18	0.72	0.36	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	27.50	3.93	0.85	0.17	0.17	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	33.84	3.82	1.02	0.25	0.25	0.00	1.02
mesothelioma cell line:No36	10857-111G2	6.20	0.98	0.00	0.33	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	63.94	2.98	0.27	0.54	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	17.66	1.34	0.19	0.77	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	15.51	2.20	0.73	0.12	0.00	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	8.79	0.90	0.18	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.22	1.31	0.00	0.33	0.33	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	34.76	3.60	0.42	0.85	0.21	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	53.67	5.76	0.23	0.46	0.23	0.92	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.34	2.09	0.57	0.57	0.00	3.62	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.78	5.54	0.92	0.92	0.18	0.37	0.37
myeloma cell line:PCM6	10474-106I6	4.15	1.58	0.20	0.00	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.71	3.55	1.01	0.51	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.71	1.96	0.78	0.20	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	31.53	4.57	0.22	0.22	0.11	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.49	2.13	0.37	0.37	0.07	0.44	0.22
nasal epithelial cells, donor2	12227-129F4	48.58	6.07	2.21	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	3.91	2.30	0.69	0.23	0.00	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	28.06	8.98	1.50	1.50	1.50	0.00	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	7.59	4.01	2.53	0.21	0.42	0.00	0.84
neuroblastoma cell line:NH-12	10555-107I6	5.78	2.24	1.49	0.56	0.00	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.27	4.03	1.90	0.24	0.47	0.00	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	18.69	9.66	3.64	0.48	0.16	0.00	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	5.64	4.43	0.81	0.00	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.81	1.91	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	2.66	0.80	0.00	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	146.97	20.97	3.04	2.20	0.00	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	2.24	1.28	0.32	0.00	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.76	3.42	1.05	0.79	0.26	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	19.40	5.16	1.12	0.37	8.16	0.19	2.44
occipital cortex - adult, donor10196	10172-103C1	22.66	2.06	0.00	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	39.99	3.22	1.61	1.07	6.98	0.54	2.95
occipital cortex, newborn, donor10223	10355-105E4	33.12	4.73	2.18	1.09	25.48	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	10.23	1.31	0.52	0.26	2.89	0.00	1.84
occipital lobe, fetal, donor1	10073-102A1	58.36	24.89	12.44	1.72	18.88	0.00	13.73
occipital pole, adult, pool1	10036-101E9	16.32	4.10	1.02	0.47	7.88	0.00	1.34
olfactory region, adult	10195-103E6	16.81	2.67	0.57	0.00	6.69	0.00	1.34
optic nerve, donor1	10277-104E7	36.02	6.00	0.00	0.00	0.00	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	52.28	4.90	0.91	0.91	0.23	1.48	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	82.84	25.69	5.77	3.30	0.14	0.55	2.20
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	36.24	4.06	0.68	0.17	0.00	0.68	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.25	2.08	0.23	1.04	0.00	0.00	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	7.64	1.76	0.59	0.59	0.00	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	3.74	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	23.54	3.82	0.42	0.42	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	29.09	4.72	1.22	0.44	0.26	0.35	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	5.68	1.65	0.18	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	24.46	6.58	1.88	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	4.75	1.40	0.84	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	65.42	5.11	0.17	1.02	0.34	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	80.31	4.97	0.66	0.50	0.00	0.50	0.83
paracentral gyrus, adult, pool1	10035-101E8	18.40	3.66	1.56	0.27	7.50	0.09	2.01
parietal cortex, adult, donor10258	10373-105G4	27.16	0.73	0.73	0.00	7.34	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	24.45	0.94	0.00	0.00	2.82	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	27.93	3.42	1.14	0.00	7.13	0.29	1.71
parietal lobe, adult, pool1	10034-101E7	17.80	3.70	1.32	0.35	10.31	0.00	1.94
parietal lobe, fetal, donor1	10072-101I9	27.16	18.43	15.52	2.91	14.55	0.00	11.64
parietal lobe, newborn, donor10223	10356-105E5	33.27	7.10	1.50	0.00	26.17	0.00	0.75
parotid gland, adult	10199-103F1	43.17	3.08	1.23	0.00	1.23	0.62	0.62
penis, adult	10200-103F2	34.38	2.15	2.15	0.00	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	3.35	2.79	1.67	0.19	0.00	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.98	3.35	0.15	0.15	0.00	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	5.16	1.94	0.00	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	14.81	1.18	0.59	0.00	4.15	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	13.80	1.25	1.25	0.00	3.76	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	16.19	3.04	1.01	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	30.23	4.69	1.56	0.00	0.52	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	17.02	0.85	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	78.05	9.03	1.94	1.18	1.61	0.32	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	26.35	3.18	0.53	0.26	0.00	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	8.87	2.33	0.16	0.16	0.00	0.00	0.47
pons, adult, pool1	10033-101E6	23.07	2.75	0.95	0.09	0.69	0.09	1.03
postcentral gyrus, adult, pool1	10032-101E5	17.52	3.66	1.39	0.26	9.24	0.00	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	4.18	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.47	2.91	1.17	0.29	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	43.89	6.17	1.09	0.54	0.27	0.54	0.82
putamen, adult, donor10196	10176-103C5	19.83	3.30	0.71	0.47	1.65	0.24	0.94
putamen, adult, donor10252	10152-102I8	37.25	5.88	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	26.23	1.09	1.09	1.09	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	14.98	1.93	0.72	0.24	2.66	0.00	1.21
putamen, newborn, donor10223	10365-105F5	18.74	2.25	0.00	0.00	3.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	16.29	2.62	0.29	0.00	0.00	0.29	0.87
rectum, fetal, donor1	10067-101I4	44.51	2.78	2.78	2.78	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.99	2.33	0.42	0.64	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.49	1.24	0.41	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	63.62	6.76	1.59	0.40	0.89	0.10	1.49
retinoblastoma cell line:Y79	10475-106I7	8.31	5.72	0.78	0.78	0.26	0.00	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.09	4.22	0.56	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	0.76	0.00	0.00	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	27.35	3.56	0.65	0.32	0.00	0.16	0.00
salivary acinar cells, donor2	11772-123I8	43.23	5.78	0.55	1.10	0.00	1.24	0.55
salivary acinar cells, donor3	11773-123I9	25.16	3.97	0.66	0.00	0.00	2.65	0.00
salivary gland, adult, pool1	10093-102C3	51.48	3.43	0.57	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.49	2.70	1.01	0.42	0.08	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.47	3.41	0.12	0.24	0.00	0.00	0.12
seminal vesicle, adult	10201-103F3	39.68	3.70	0.00	1.06	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	41.54	2.92	0.73	0.24	0.24	1.21	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	60.14	8.30	0.75	1.26	0.50	0.00	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	86.30	14.05	5.02	2.01	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	175.15	10.75	1.61	2.01	0.00	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	25.42	3.65	0.66	0.66	0.00	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.74	3.74	0.13	0.65	0.13	0.52	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	21.35	2.16	0.36	0.12	0.00	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	31.16	12.06	3.02	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	74.64	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	50.50	7.57	2.52	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.34	5.67	1.00	0.33	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.29	3.47	1.26	0.63	0.32	0.00	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	2.89	6.55	3.28	0.39	0.58	0.00	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	17.31	3.96	1.15	1.48	0.16	0.00	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.39	5.95	0.97	0.48	0.32	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.46	1.96	1.53	1.09	0.44	0.00	0.65
small intestine, adult, pool1	10024-101D6	50.64	3.82	0.48	0.60	0.12	0.24	0.24
small intestine, fetal, donor1	10064-101I1	35.63	4.67	1.72	0.98	0.00	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	4.10	0.51	0.00	0.00	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	23.00	1.81	0.52	0.52	0.00	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	6.43	2.41	0.80	0.27	0.00	0.00	1.07
spinal cord - adult, donor10196	10181-103D1	36.93	3.67	0.00	0.23	0.00	0.23	1.84
spinal cord, adult, donor10252	10159-103A6	46.92	3.94	0.39	1.18	0.39	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	26.98	0.69	0.00	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	53.06	9.15	1.22	1.83	0.61	0.00	4.88
spinal cord, newborn, donor10223	10359-105E8	37.20	2.76	0.92	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	8.21	1.94	0.15	0.45	0.00	0.00	0.90
spleen, adult, pool1	10025-101D7	62.34	6.06	0.11	0.55	0.11	0.55	0.00
spleen, fetal, pool1	10044-101F8	78.74	7.07	1.03	1.35	0.08	1.75	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	45.44	4.87	0.10	0.93	0.00	1.86	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.96	3.04	0.19	0.57	0.19	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	33.20	6.64	0.70	0.35	1.05	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	20.33	0.78	0.39	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	8.78	1.80	0.11	0.34	0.23	0.45	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	42.78	7.62	0.42	0.00	0.42	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	12.27	5.50	0.42	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	18.16	1.07	0.00	0.00	0.00	0.00	2.14
submaxillary gland, adult	10202-103F4	42.73	3.42	0.00	0.00	0.00	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	52.76	4.78	1.66	0.00	0.42	0.21	1.04
substantia nigra, adult, donor10258	10371-105G2	15.00	1.03	0.00	0.00	1.03	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	33.21	3.53	0.71	0.71	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	10.32	6.42	2.75	1.38	0.00	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	20.18	3.98	1.78	0.42	12.29	0.08	2.46
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.17	20.66	13.53	0.71	15.67	0.00	22.08
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	42.64	19.78	14.07	2.20	18.90	0.00	13.19
tenocyte, donor1	11763-123H8	10.82	1.05	0.35	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	23.27	3.43	0.00	0.38	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	6.67	2.22	0.00	0.00	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	16.49	6.29	1.19	0.51	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	24.51	5.40	0.77	0.00	0.15	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	8.52	3.72	0.62	0.77	0.00	0.00	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.30	3.43	0.76	0.38	0.00	0.00	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.94	1.89	0.76	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.98	1.53	0.22	0.11	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.70	3.91	1.95	0.65	0.00	0.00	0.98
testis, adult, pool1	10026-101D8	40.91	6.23	1.83	0.97	3.54	0.00	1.61
testis, adult, pool2	10096-102C6	25.71	4.06	1.80	0.90	4.96	0.00	2.26
thalamus - adult, donor10196	10168-103B6	50.78	3.31	0.00	0.00	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	40.95	5.47	1.41	0.31	0.78	0.00	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	3.08	0.00	0.00	6.16	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.60	1.81	1.48	0.33	1.81	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	43.15	6.33	1.73	0.58	13.81	1.15	0.58
throat, adult	10209-103G2	45.19	2.75	0.00	0.25	0.00	1.50	0.50
throat, fetal, donor1	10061-101H7	46.92	9.14	1.83	0.00	0.00	0.61	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	4.17	5.37	2.58	0.40	0.60	0.00	1.19
thymus, adult, pool1	10027-101D9	31.71	7.95	2.19	0.89	0.00	0.60	1.09
thymus, fetal, pool1	10043-101F7	70.45	9.97	3.01	1.14	0.21	2.18	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.27	2.79	0.27	0.80	0.13	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	9.50	2.65	0.28	0.14	0.00	0.00	0.28
thyroid, adult, pool1	10028-101E1	65.04	7.65	1.59	0.47	0.19	1.31	0.56
thyroid, fetal, donor1	10060-101H6	50.89	3.69	1.58	0.26	0.26	0.26	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	38.84	3.02	0.23	0.47	0.23	0.47	0.47
tongue, fetal, donor1	10059-101H5	39.80	4.73	1.18	0.79	0.79	0.00	0.79
tonsil, adult, pool1	10047-101G2	71.53	6.61	0.60	0.70	0.10	3.61	0.40
trachea, adult, pool1	10029-101E2	52.84	4.34	0.41	0.98	0.25	1.55	0.33
trachea, fetal, donor1	10058-101H4	43.09	3.46	1.15	0.77	0.00	1.92	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.02	1.42	0.35	0.35	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	18.44	3.55	1.01	0.81	0.00	0.00	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.27	5.95	2.04	1.25	0.00	0.00	0.63
tridermal teratoma cell line:HGRT	10694-109G1	1.90	1.90	1.90	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.73	3.13	0.59	0.42	0.08	0.00	0.25
umbilical cord, fetal, donor1	10057-101H3	27.12	6.26	4.17	0.00	0.00	4.17	2.09
uterus, adult, pool1	10100-102D1	47.78	3.75	1.02	0.51	0.51	0.34	0.34
uterus, fetal, donor1	10055-101H1	54.78	9.73	2.56	1.02	0.00	0.51	1.54
vagina, adult	10204-103F6	60.74	1.29	1.29	0.00	0.00	0.65	0.65
vein, adult	10191-103E2	65.98	4.16	0.88	0.22	0.22	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.87	2.14	0.53	0.27	0.27	0.00	0.00